ArticleProbiotics and antimicrobial proteins2026
Fish-Derived Clostridium butyricum LZK-08: Genomic Insights and Probiotic Evaluation in Largemouth Bass.
Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Combination Effects ofBiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Clostridium butyricum has gained attention as a probiotic in aquaculture due to its ability to improve growth, gut health, and immune function. However, most strains currently used are derived from non-aquatic sources, which may limit their colonization and efficacy in fish. In this study, a novel strain, C. butyricum LZK-08, was isolated from the intestine of grass carp. The strain was identified based on morphological features, 16S rRNA sequencing, and whole-genome analysis. Its probiotic properties were assessed through comprehensive in vitro assays and in vivo trials in largemouth bass. LZK-08 exhibited strong acid (pH 4.0), bile salt (0.3%), and heat (up to 80 °C) tolerance, along with high auto-aggregation (92.3%) and notable surface hydrophobicity. It produced digestive enzymes (amylase, protease, lipase) and short-chain fatty acids, particularly butyrate (523.32 μg/mL). Genomic analysis revealed a 4.71 Mb genome composed of a circular chromosome and plasmid, encoding 4,207 protein-coding genes. Key genes were enriched in carbohydrate and amino acid metabolism, stress response, and adhesion. Feeding trials in largemouth bass showed that dietary supplementation with LZK-08 significantly improved growth parameters, reduced feed conversion ratio, enhanced intestinal antioxidant enzyme and digestive enzyme activities. Histological analysis revealed improved intestinal morphology, including increased villus height and muscle thickness. 16S rRNA sequencing further showed that LZK-08 modulated gut microbiota by enriching beneficial taxa such as Lactobacillus and reducing potentially unfavorable Romboutsia. These findings indicate that C. butyricum LZK-08 is a physiologically robust, and genomically safe probiotic with strong functional attributes, demonstrating high potential for use in sustainable aquaculture.
Indexed as
Identifiers
40911131What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.